Pneumagen
PrivateLast Round
Early Funding
Jun 1, 2023
Total Funding Raised
$10M
Momentum Score
25 /100
Company Overview
Pneumagen is a biotechnology company developing Neumifil, a broad-spectrum, intranasal antiviral for the prophylaxis and treatment of viral respiratory tract infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pneumagen Comps
Public and private peers based on sector, stage, and business model.
Pneumagen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 1, 2023 | ||||
| VC Round | Jan 21, 2022 | ||||
| VC Round | Jan 21, 2021 | ||||
| VC Round | May 27, 2020 |
Key People
Founding team and executive leadership
Pneumagen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Esperante Ventures | Early Funding |
| Scottish National Investment Bank | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | Early Funding, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 79% MoM, reaching 1.2K.
- Sep 17, 2025
Launched NeumoBind technology platform for intranasal therapeutics.
Pneumagen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pneumagen's valuation, stock price, and market status.
